Skip to main content
logo
Lin BioScience, Inc. (TPEX:6696)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
169.00
+6.00 (3.68%)
Sep 17, 2026, 2:05 PM CST

Lin BioScience Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
135,16032,84210,8128,94612,58312,832
Market Cap Growth
908.54%203.77%20.85%-28.90%-1.94%83.66%
Enterprise Value
133,62330,1558,4977,78811,31411,817
Last Close Price
163.0039.7013.6611.3217.0318.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
5.291.312.022.617.2528.33
P/TBV Ratio
12.903.093.954.4111.1828.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.010.030.01
Net Debt / Equity Ratio
-0.65-0.65-0.97-0.94-0.92-1.78
Net Debt / EBITDA Ratio
4.175.713.572.953.612.39
Net Debt / FCF Ratio
7.2111.235.053.174.172.76
Quick Ratio
37.5457.6833.6623.7020.601.72
Current Ratio
38.0858.1834.4524.6920.941.74
Return on Equity (ROE)
-21.83%-16.93%-28.66%-41.08%-41.98%-70.57%
Return on Assets (ROA)
-15.73%-11.54%-19.97%-25.16%-20.05%-19.74%
Return on Capital Employed (ROCE)
-15.50%-11.40%-27.10%-31.70%-25.10%-74.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.19%-4.15%-6.88%-7.68%-2.49%-3.39%
FCF Yield
-1.69%-4.41%-9.48%-11.34%-3.05%-2.27%
Buyback Yield / Dilution
-3.46%-4.46%-6.24%-3.14%-4.27%-10.73%